Characteristics | With VTE N = 312 | Without VTE N = 248 | P |
---|---|---|---|
Patient data | |||
 Age, y, IQR | 66.0 (60.0–73.0) | 64.0 (57.0–70.8) | 0.001 |
  ≥ 65 years, N (%) | 190 (60.9) | 114 (46.0) | < 0.001 |
 Male, N (%) | 199 (63.8) | 166 (66.9) | 0.437 |
 BMI, ± SD (kg/m2) | 24.2 ± 3.8 | 23.6 ± 4.0 | 0.077 |
  ≥ 25 (kg/m2), N (%) | 119 (38.1) | 82 (33.1) | 0.214 |
 Smoking history, N (%) | 119 (38.1) | 105 (42.3) | 0.314 |
 Past alcohol use, N (%) | 79 (25.3) | 64 (25.8) | 0.896 |
Comorbidities, N (%) | |||
 Diabetes | 57 (18.3) | 55 (22.2) | 0.251 |
 Hypertension | 135 (43.3) | 98 (39.5) | 0.371 |
 Prior VTE | 56 (17.9) | 3 (1.2) | < 0.001 |
 MACCE | 55 (17.6) | 51 (20.6) | 0.378 |
Causes of ICU admission | Â | Â | 0.002 |
 Surgical, N (%) | 205 (65.7) | 192 (77.4) |  |
 Medical, N (%) | 107 (34.3) | 56 (22.6) |  |
Tumor category, N (%) | Â | Â | 0.244 |
 Lung cancer | 17 (5.4) | 16 (6.5) |  |
 Hepatobiliary and pancreatic tumors | 28 (9.0) | 15 (6.0) |  |
 Tumors of digestive system | 199 (63.8) | 167 (67.3) |  |
 Breast cancer | 15 (4.8) | 3 (1.2) |  |
 Gynecological tumors | 11 (3.5) | 10 (4.0) |  |
 Retroperitoneal masses | 21 (6.7) | 19 (7.7) |  |
 Others* | 21 (6.7) | 18 (7.3) |  |
Stagea | Â | Â | 0.513 |
 1–3, N (%) | 216 (71.1) | 165 (68.5) |  |
 4, N (%) | 88 (28.9) | 76 (31.5) |  |
Gradea | Â | Â | 0.002 |
 1–2, N (%) | 160 (52.6) | 158 (65.6) |  |
 3–4, N (%) | 144 (47.4) | 83 (34.4) |  |
Baseline test results | |||
 WBC, ×109/L, IQR | 5.9 (4.6–7.3) | 5.7 (4.6–7.6) | 0.755 |
 Hemoglobin, g/L, IQR | 124.0 (103.3–141.0) | 123.5 (101.0–141.8) | 0.984 |
 Platelet, ×109/L, IQR | 198.0 (153.3–266.8) | 181.5 (137.5–251.0) | 0.044 |
 Creatinine, μmol/L, IQR | 64.0 (53.0–74.0) | 67.0 (55.0–81.0) | 0.742 |
 Albumin, g/L, IQR | 41.4 (37.9–44.7) | 41.9 (37.4–44.8) | 0.479 |
 Bilirubin, μmol/L, IQR | 12.6 (9.1–17.6) | 12.1 (8.4–16.7) | 0.120 |
 Glucose, mmol/L, IQR | 5.7 (5.1–6.9) | 5.6 (5.0–6.8) | 0.985 |
 TC, mmol/L, IQRb | 4.37 (3.81–5.17) | 4.26 (3.52–4.98) | 0.039 |
 TG, mmol/L, IQRb | 1.18 (0.85–1.74) | 1.24 (0.85–1.85) | 0.299 |
ABO blood group, N (%)c | Â | Â | 0.216 |
 A | 86 (27.8) | 85 (34.4) |  |
 B | 100 (32.4) | 66 (26.7) |  |
 AB | 32 (10.4) | 31 (12.6) |  |
 O | 91 (29.4) | 65 (26.3) |  |
APTT, s, IQR | 30.1 (27.6–34.0) | 31.0 (28.5–35.3) | 0.362 |
INR, IQR | 1.02 (0.97–1.08) | 1.04 (0.98–1.14) | 0.131 |
D-dimer, μmol/L, IQRd | 1.18 (0.75–2.51) | 1.03 (0.67–2.12) | 0.052 |
APECHE II | 10 (7–13) | 9 (7–12) | 0.145 |